VIP and rheumatoid arthritis: Research in human models has confirmed the modulatory effects of VIP in ex vivo assays with fibroblast-like synoviocytes and peripheral blood lymphocytes from patients with RA through down-regulation of proinflammatory mediators [16]–[18].